• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

Medical News Today: Why does olive oil keep heart attack and stroke at bay?
A new study shows that the protein ApoA-IV, which rises in the blood after eating (especially unsaturated fats), prevents thrombosis by blocking platelets.
Source: Health News from Medical News Today - September 7, 2018 Category: Consumer Health News Tags: Cardiovascular / Cardiology Source Type: news

UNC researchers find promising platelet protein that could offer new angle for developing drugs to prevent thrombosis
Platelets, which allow blood to clot, are at the heart of numerous cardiovascular problems, including heart attacks and stroke. New research has uncovered a key platelet protein that could offer a new angle for developing drugs to prevent thrombosis, or dangerous blood clots, in patients who are at high risk such as those with atherosclerosis or a history of heart problems...
Source: Health News from Medical News Today - September 4, 2013 Category: Consumer Health News Tags: Vascular Source Type: news

Waking up to new treatments for stroke - WAKE-UP trial starts in the UK
WAKE-UP - a large European clinical trial to test whether current 'clot dissolving' treatments can be used in people who wake up with the symptoms of stroke enrolled the first UK patients at the Southern General Hospital this week. Every year about two million patients have a stroke in the EU. Up to 20 per cent of stroke patients wake up with stroke symptoms so the time the stroke started is unknown. This makes patients ineligible for the only approved treatment for acute stroke- the delivery the thrombolytic or 'clot dissolving' drug rtPA...
Source: Health News from Medical News Today - July 29, 2013 Category: Consumer Health News Tags: Stroke Source Type: news

Earlier Treatment Following Stroke Onset Associated With Reduced Risk Of In-Hospital Death, Higher Rate Of Discharge To Home
In a study that included nearly 60,000 patients with acute ischemic stroke, thrombolytic treatment (to help dissolve a blood clot) that was started more rapidly after symptom onset was associated with reduced in-hospital mortality and intracranial hemorrhage and higher rates of independent walking ability at discharge and discharge to home, according to a study in the June 19 issue of JAMA. "Intravenous (IV) tissue-type plasminogen activator (tPA) is a treatment of proven benefit for select patients with acute ischemic stroke as long as 4.5 hours after onset...
Source: Health News from Medical News Today - June 20, 2013 Category: Consumer Health News Tags: Stroke Source Type: news

Speed Vital For Stroke Patients' Survival
The sooner stroke patients receive thrombolytic treatment, the lower their risk of in-hospital mortality and intracranial hemorrhage, says a new study published in JAMA (Journal of the American Medical Association). In addition, the prompter the treatment, the higher the rate of walking ability at discharge. Intravenous (IV) tissue-type plasminogen activator (tPA) is a form of treatment proven to help stroke patients within 4.5 hours of onset of symptoms...
Source: Health News from Medical News Today - June 19, 2013 Category: Consumer Health News Tags: Stroke Source Type: news

What Is Warfarin?
Warfarin is an anticoagulant medication - it is used to slow down the blood-clotting process. Anticoagulants are used to prevent blood clots which may cause vein blockages, heart attack and stroke. Warfarin is known under the brand names Warfant, Jantoven, Coumadin, Lawarin, Marevan, and Waran. Doctors prescribe warfarin for people who are at a higher risk of forming blood clots. Examples include patients with..: ..blood clots in the veins of the legs (deep vein thrombosis) ..a blood clot in the lungs (pulmonary embolism) ..an irregular heart beat (atrial fibrillation)...
Source: Health News from Medical News Today - June 1, 2013 Category: Consumer Health News Tags: Blood / Hematology Source Type: news